Management of a Positive Coombs Test
Diagnostic Evaluation
- A positive Coombs test indicates the presence of antibodies attached to red blood cells, which may lead to hemolytic anemia in some cases 1
- Initial evaluation should include a complete blood count with indices, peripheral blood smear, reticulocyte count, and markers of hemolysis (e.g. indirect bilirubin) 2, 3
- Peripheral blood smear examination is critical to look for evidence of hemolysis such as schistocytes or spherocytes 3
- Evaluate for underlying causes of a positive Coombs test, including medications that can cause drug-induced hemolysis 3 and autoimmune disorders 2
- Recent transfusions should also be considered as a potential cause of a positive Coombs test 2
Management Based on Clinical Presentation
- For patients without evidence of hemolysis, monitor hemoglobin levels and signs of hemolysis periodically 2
- For patients with mild hemolysis, identify and treat the underlying cause if possible, and consider low-dose corticosteroids if autoimmune hemolysis is suspected 3, 4
- For patients with moderate to severe hemolysis, initiate corticosteroid therapy and consider blood transfusions for severe anemia 1, 3, 4
- If immune checkpoint inhibitor therapy is the cause, permanently discontinue the treatment 4
Special Considerations
- In patients with cancer receiving immunotherapy, a positive Coombs test may indicate immune-related adverse events 1, 4
- Approximately 40% of immune-related autoimmune hemolytic anemia cases may be Coombs-negative, requiring high clinical suspicion 1
- Management depends on severity grade, with permanent discontinuation of immune checkpoint inhibitors for grade 3-4 toxicity 4
Follow-up and Monitoring
- Regular monitoring of hemoglobin levels, reticulocyte count, and markers of hemolysis is necessary 2
- Adjust treatment based on clinical response and laboratory parameters 3
- For patients with resolved hemolysis, gradually taper corticosteroids to avoid relapse 3